![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1434485
¼¼°è Áß¾ÓÁ¶Á¦¾à±¹ ÀÚµ¿È ½ÃÀå : Á¡À¯À² ºÐ¼®, »ê¾÷ µ¿Çâ ¹× Åë°è, ¼ºÀå ¿¹Ãø(2024-2029³â)Central Fill Pharmacy Automation - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) |
Áß¾ÓÁ¶Á¦¾à±¹ ÀÚµ¿È ½ÃÀå ±Ô¸ð´Â 2024³â 7¾ï 1,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2029³â±îÁö 12¾ï 2,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø±â°£(2024-2029³â) µ¿¾È 11.32%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.
ÃÖ±Ù Áß¾Ó Á¶Á¦ ¾à±¹ÀÇ Ã¤¿ë Áõ°¡ÀÇ ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ´Ù¾çÇÑ ¾Ï°ú ¸é¿ª ÁúȯÀÇ ¼¼°è À¯º´·ü Áõ°¡, Åõ¾à ½Ç¼ö¸¦ ÁÙÀÎ Àü¹® ¾à¹°ÀÇ ÀÚµ¿ Á¦Á¦ÀÇ Çʿ伺, ³ëÀÎ Àα¸ÀÇ Àǵµ ÇÏÁö ¾Ê´Â »óÇØ Áõ°¡ µîÀ» µé ¼ö ÀÖ°í, ½Å¼ÓÇϰí Á¤È®ÇÑ ´ëÀÀÀÌ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. ¾à¹° °ø±Þ. ¿¹¸¦ µé¾î ¼¼°èº¸°Ç±â±¸ÀÇ º¸°í¼(2018³â)¿¡ µû¸£¸é 65¼¼ ÀÌ»óÀÇ »ç¶÷ÀÇ ¾à 28-35%´Â ¸Å³â °¨¼ÒÇϰí 70¼¼ À̻󿡼´Â 32-42%·Î Áõ°¡Çϰí ÀÖÀ¸¸ç ¾ÕÀ¸·Î ´õ¿í Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½ÃÀåÀ» ÀÚ±ØÇÏ´Â ±â°£. ¶ÇÇÑ, ÀÚµ¿È µµÀÔÀ¸·Î ÀΰǺñ Àý°¨Àº ¿¹Ãø ±â°£ µ¿¾È Áß¾Ó Á¶Á¦ ¾à±¹ ÀÚµ¿È ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ ¼ö ÀÖ½À´Ï´Ù.
¹Ì±¹¿¡´Â ¾öû³ ¼öÀÇ ³ëÀΠȯÀÚ¿Í ºñ¸¸ ȯÀÚ°¡ ÀÖÀ¸¸ç ÀÌ·Î ÀÎÇØ Áß¾Ó Á¶Á¦ ¾à±¹ ¸ðµ¨À» ¿ä±¸Çϱ⠶§¹®¿¡ ºÏ¹Ì´Â ¿¹Ãø ±â°£ µ¿¾È Áß¾Ó Á¶Á¦ ¾à±¹ ÀÚµ¿È ½ÃÀå Àüü¸¦ Áö¹èÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, 2018³â ¹Ì±¹ ÀÇ»çȸ º¸°í¼´Â ¾à 9,330¸¸ ¸íÀÇ ¹Ì±¹¿¡ ÇØ´çÇÏ´Â 20¼¼ ÀÌ»óÀÇ ¼ºÀÎÀÇ °ÅÀÇ 40%°¡ ºñ¸¸À̸ç, ¿¹Ãø ±â°£ µ¿¾È ºñ¸¸ÀÌ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡, Àü¹® ¾à¹°ÀÇ Á¦Çü¿¡¼ Àΰ£ÀÇ °³ÀÔÀ¸·Î ÀÎÇÑ Åõ¾à ½Ç¼ö Áõ°¡·Î ÀÎÇØ ¹Ì±¹¿¡¼´Â ȯÀÚ¿¡°Ô °¡Ä¡ ±â¹Ý Ä¡·á¸¦ Á¦°øÇÏ´Â µ¥ ÁßÁ¡À» µÐ ¼ö¿ä°¡ ±Þ°ÝÈ÷ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÃæÀü, Æ÷Àå, ¶óº§ ºÎÂøÀÇ ÀΰǺñ Àý°¨°ú Á¦Çü ¹× Á¦Á¦ °È¿¡ ÀÇÇÑ ÀÚµ¿È ½Ã½ºÅÛÀ¸·ÎÀÇ ÀÌÇà Áõ°¡°¡ ÀÌ ½ÃÀå¿¡¼ ÁÖ¸ñÀ» ¹Þ°í ÀÖÀ¸¸ç, ºÏ¹Ì Áß¾ÓÃæÀü ¾à±¹ ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇÏ°í °ÉÃâ ÇÑ ½ÃÀå ¼öÀÍ¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Àüü ¿¹Ãø ±â°£ÀÇ Á¡À¯À².
Áß¾Ó Á¶Á¦ ¾à±¹ ÀÚµ¿È ½ÃÀåÀº Àû´çÇÑ °æÀïÀ» °¡Áö°í ÀÖÀ¸¸ç ¿©·¯ ÁÖ¿ä ±â¾÷À¸·Î ±¸¼ºµÇ¾î ÀÖ½À´Ï´Ù. ½ÃÀå Á¡À¯À²ÀÇ °üÁ¡¿¡¼ º¸¸é Áß¾Ó Á¶Á¦ ¾à±¹ ¸ðµ¨À» Á¦°øÇÔÀ¸·Î½á ¼ºñ½º¸¦ °ÈÇÏ´Â »õ·Î¿î ¹æ¹ýÀÇ °³¹ß¿¡ ÁÖ·ÂÇÏ´Â ´ë±â¾÷Àº °ÅÀÇ ¾ø½À´Ï´Ù. Àú¸íÇÑ ±â¾÷µµ Á¦Ç° ½ÂÀÎ ¹× Á¦Ç° Ãâ½Ã¿¡ ÁÖ·ÂÇϰí ÀÖÀ¸¸ç, Àü ¼¼°è¿¡¼ ÀÌ ½ÃÀå¿¡¼ »ç¾÷À» Àü°³Çϰí ÀÖ´Â ´Ù¸¥ ±â¾÷°ú Àü·«Àû Á¦ÈÞ¸¦ È®¸³Çϰí Çù·ÂÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2018³â 11¿ù, ¾à±¹ ÀÚµ¿È ¾÷°è¸¦ ¼±µµÇÏ´Â ARxIUMÀº ½ÃÀå¿¡¼ À¯ÀÏÇÏ°Ô ¿ÏÀüÈ÷ ÀÚµ¿ÈµÈ cGMP ½Ã½ºÅÛÀÎ 503B Áß¾Ó Á¶Á¦ ¾à±¹, º´¿ø ¹× À§Å¹ ¾à±¹¿ë cGMP RIVA IV Á¦Á¦ ½Ã½ºÅÛÀ» Ãâ½Ã Çß½À´Ï´Ù. ÇöÀç ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ´Â ±â¾÷À¸·Î´Â McKesson Corporation, Parata Systems LLC, Omnicell Inc, ARxIUM Inc, RxSafe LLC µîÀÌ ÀÖ½À´Ï´Ù.
The Central Fill Pharmacy Automation Market size is estimated at USD 0.71 billion in 2024, and is expected to reach USD 1.22 billion by 2029, growing at a CAGR of 11.32% during the forecast period (2024-2029).
The major factors attributing to the increased adoption of central fill pharmacies in recent years include growth inthe global prevalence of various cancers, immunological disorders, necessitating the automated dispense of specialty drugs with reduced medication errors and increasing unintentional injuries in geriatric population demands the fastest and accurate supply of medication. For instance, according to the World Health Organization Report - 2018, about 28-35% of people aged 65 and over, fall each year increasing to 32-42% for those over 70 years of age, which is expected to rise in the forecast period fueling the market. Moreover, the reduction of labor costs with the adoption of automation is likelyto drive the growth of the central fill pharmacy automation market throughout the forecast period.
North America is expected to dominate the overall central fill pharmacy automation market throughout the forecast period due to the presence of the huge number of geriatric patients and obese patients in the United States demanding the central fill pharmacy model owing to their advantages. For instance, the American Medical Association report in 2018, nearly 40% of adults over the age of 20 representing about 93.3 million people in the United States were obese, projected to increase in the forecast period driving the market. Furthermore, a rise in the growing number of medication errors due to human intervention in specialty medication dispenses resulting in steep growth of demand to focus on providing value-based care to patients in the United States. Also, an increase in the shift towards automated systems due to reduced labor costs for filling, packaging, and labeling coupled with enhanced compounding and dispensing has drawn attention in this market driving the demand in North America central fill pharmacy market contributing to its outstanding market revenue share throughout the forecast period.
The central fill pharmacy automation market is moderately competitive and consists of several major players. In terms of market share, few of the major players are focusing on developing new ways to enhance the services by providing a central fill pharmacy model. Prominent players are also focusing on product approvals, product launch, and are engaged in establishing a strategic alliance and collaborating with other companies operating in this market across the globe. For example, in November 2018, ARxIUM, a leading pharmacy automation industry launched a cGMP RIVA IV compounding system for 503B central-fill, hospital and outsourcing pharmacies which is the only fully automated cGMP system on the market. Some of the companies currently dominating the market are McKesson Corporation, Parata Systems LLC, Omnicell Inc, ARxIUM Inc, and RxSafe LLC.